Literature DB >> 30214875

Metabolic effects of sacubitril/valsartan: are they relevant in clinical practice?

Rafael de la Espriella-Juan1, Juan Sanchis1,2, Antoni Bayés-Genís2,3,4, Julio Núñez1,2.   

Abstract

Entities:  

Year:  2018        PMID： 30214875      PMCID： PMC6129840          DOI： 10.21037/cdt.2018.07.05

Source DB:  PubMed          Journal:  Cardiovasc Diagn Ther        ISSN： 2223-3652


× No keyword cloud information.
  28 in total

1.  Effect of sacubitril/valsartan versus enalapril on glycaemic control in patients with heart failure and diabetes: a post-hoc analysis from the PARADIGM-HF trial.

Authors:  Jelena P Seferovic; Brian Claggett; Sara B Seidelmann; Ellen W Seely; Milton Packer; Michael R Zile; Jean L Rouleau; Karl Swedberg; Martin Lefkowitz; Victor C Shi; Akshay S Desai; John J V McMurray; Scott D Solomon
Journal:  Lancet Diabetes Endocrinol       Date:  2017-03-18       Impact factor: 32.069

2.  The atrial natriuretic peptide and guanylyl cyclase-A system modulates pancreatic beta-cell function.

Authors:  Ana B Ropero; Sergi Soriano; Eva Tudurí; Laura Marroquí; Noelia Téllez; Birgit Gassner; Pablo Juan-Picó; Eduard Montanya; Ivan Quesada; Michaela Kuhn; Angel Nadal
Journal:  Endocrinology       Date:  2010-06-16       Impact factor: 4.736

3.  Involvement of a cGMP-dependent pathway in the natriuretic peptide-mediated hormone-sensitive lipase phosphorylation in human adipocytes.

Authors:  Coralie Sengenes; Anne Bouloumie; Hans Hauner; Michel Berlan; Rudi Busse; Max Lafontan; Jean Galitzky
Journal:  J Biol Chem       Date:  2003-09-10       Impact factor: 5.157

4.  Improved Insulin Sensitivity With Angiotensin Receptor Neprilysin Inhibition in Individuals With Obesity and Hypertension.

Authors:  J Jordan; R Stinkens; T Jax; S Engeli; E E Blaak; M May; B Havekes; C Schindler; D Albrecht; P Pal; T Heise; G H Goossens; T H Langenickel
Journal:  Clin Pharmacol Ther       Date:  2016-11-17       Impact factor: 6.875

5.  Natriuretic peptides enhance the oxidative capacity of human skeletal muscle.

Authors:  Stefan Engeli; Andreas L Birkenfeld; Pierre-Marie Badin; Virginie Bourlier; Katie Louche; Nathalie Viguerie; Claire Thalamas; Emilie Montastier; Dominique Larrouy; Isabelle Harant; Isabelle de Glisezinski; Stefanie Lieske; Julia Reinke; Bibiana Beckmann; Dominique Langin; Jens Jordan; Cedric Moro
Journal:  J Clin Invest       Date:  2012-11-01       Impact factor: 14.808

Review 6.  Natriuretic peptides and fat metabolism.

Authors:  Cedric Moro
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2013-11       Impact factor: 4.294

Review 7.  Amyloid-clearing proteins and their epigenetic regulation as a therapeutic target in Alzheimer's disease.

Authors:  Natalia N Nalivaeva; Nikolai D Belyaev; Caroline Kerridge; Anthony J Turner
Journal:  Front Aging Neurosci       Date:  2014-09-17       Impact factor: 5.750

8.  Effect of Sacubitril/Valsartan on Exercise-Induced Lipid Metabolism in Patients With Obesity and Hypertension.

Authors:  Stefan Engeli; Rudi Stinkens; Tim Heise; Marcus May; Gijs H Goossens; Ellen E Blaak; Bas Havekes; Thomas Jax; Diego Albrecht; Parasar Pal; Uwe Tegtbur; Sven Haufe; Thomas H Langenickel; Jens Jordan
Journal:  Hypertension       Date:  2017-11-27       Impact factor: 10.190

9.  Dementia-related adverse events in PARADIGM-HF and other trials in heart failure with reduced ejection fraction.

Authors:  Jane A Cannon; Li Shen; Pardeep S Jhund; Søren L Kristensen; Lars Køber; Fabian Chen; Jianjian Gong; Martin P Lefkowitz; Jean L Rouleau; Victor C Shi; Karl Swedberg; Michael R Zile; Scott D Solomon; Milton Packer; John J V McMurray
Journal:  Eur J Heart Fail       Date:  2016-11-20       Impact factor: 15.534

10.  The effect of LCZ696 (sacubitril/valsartan) on amyloid-β concentrations in cerebrospinal fluid in healthy subjects.

Authors:  Thomas H Langenickel; Chiaki Tsubouchi; Surya Ayalasomayajula; Parasar Pal; Marie-Anne Valentin; Markus Hinder; Stanford Jhee; Hakop Gevorkyan; Iris Rajman
Journal:  Br J Clin Pharmacol       Date:  2016-03-08       Impact factor: 4.335
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.